Mostrando 10 resultados de: 19
Filtros aplicados
Publisher
Revista Latinoamericana de Hipertension(5)
Current Pharmaceutical Design(4)
International Journal of Molecular Sciences(3)
American Journal of Therapeutics(1)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Área temáticas
Enfermedades(15)
Fisiología humana(9)
Medicina y salud(2)
Salud y seguridad personal(2)
Bioquímica(1)
Chronobiology and chronotherapy in depression: Current knowledge and chronotherapeutic promises
ArticleAbstract: Background: Depression is a heavily prevalent mental disorder. Symptoms of depression extend beyondPalabras claves:Agomelatine, Chronobiology, Chronodisruption, Chronotherapy, Depression, SleepAutores:Batista M.J., Cano-Ponce C., Chávez-Castillo M., Díaz E.A., González M.C., Ortega A., Pírela D., Riaño M., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusAnti-aging effect of metformin: A molecular and therapeutical perspective
ReviewAbstract: Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has aPalabras claves:ageing, Anti-ageing drugs, Geronto-protective properties, Metformin, Type 2 Diabetes mellitusAutores:Cano-Ponce C., D’marco L., Galbán N., Gomez Y., González M.C., Herazo Y., Morillo V., Nava M., Rojas M., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusA tale about perfect partners: New horizons in glimepiride and metformin Mechanisms of action
ArticleAbstract: The sustainability of the effects, the improvement of directly damaged and associated organ dysfunctPalabras claves:AMP-dependent kinase, Glimepiride, Glucose transporters, K channel ATP, Lipid rafts, Metformin, Mitochondrial bioenergeticsAutores:Añez-Ramos R., Calvo M.J., Cerda M., Contreras-Velásquez J.C., Garicano C.M.D., González M.C., Graterol-Rivas M., Joselyn Zula, Lalinde J.H., Martínez M.S., Rojas E.R., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Wilches-Duran S.Fuentes:googlescopusExploratory study of the behavior of lipidic profile, malondialdehyde and nitric oxide in individuals of the Yukpa ethnic group from Zulian state, Venezuela
ArticleAbstract: Introduction: an abnormal lipidic profile is a risk indicator for cardiovascular diseases associatedPalabras claves:cardiovascular diseases, HDL, Lipidic profile, Malondialdehyde, Nitric oxideAutores:Acosta L., Amell A., Cano-Ponce C., Colmenares C., González M.C., Medina M.T., Nuñez M., Perez A., Rincón L., Seyfi H.A., Souki-Rincón A., Urribarri J., Valmore Bermúdez, Viloria A.Fuentes:scopusExploring phytotherapeutic alternatives for obesity, insulin resistance and diabetes mellitus
ReviewAbstract: At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) repre-Palabras claves:Cardiovascular disease, diabetes mellitus, Insulin Resistance, Medicinal herbs, obesity, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Nuñez V., Ortega A., Pírela D., Rojas M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusEffects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects
ArticleAbstract: The objective is to determine cardiovascular and insulin release effects under metoclopramide (MTC)Palabras claves:dopamine, Dopamine receptors, Hypertension, Insulin release, Metoclopramide, Type 2 DiabetesAutores:Bolívar H., Cano R.A., Contreras F., Fouillioux C., González M.C., Hernández-Hernandez R., Lares M., Valmore Bermúdez, Velasco M.Fuentes:scopusNeprilysin: A potential therapeutic target of arterial hypertension?
ReviewAbstract: Arterial hypertension is the most prevalent chronic disease in the adult population of developed couPalabras claves:Arterial hypertension, Heart Failure, Natriuretic peptides, Neprilysin, Pharmacology, SacubitrilAutores:Cano-Ponce C., Carrasquero R., Cristobal Ignacio Espinoza Díaz, González M.C., Pérez J.L., Ramírez P., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore BermúdezFuentes:scopusImportance of high triglycerides levels between novel coronary risk factors
ArticleAbstract: Introduction The analysis of new cardiovascular risk factors is under an extensive debate in the carPalabras claves:Insulin, lipids, prevention, RISK FACTORSAutores:Añez-Ramos R., Calvo M.J., González M.C., Graterol M., Hernández J.D., Martínez M.S., Rivas-Ríos J.R., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusMetabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
ReviewAbstract: The constant changes in cancer cell bioenergetics are widely known as metabolic repro-gramming. ReprPalabras claves:Carbohydrates, Energy metabolism, immunotherapy, inflammation, Metabolic reprogramming, neoplasms, tumor microenvironmentAutores:de Sanctis J.B., Galbán N., Garrido B., González M.C., Navarro C., Ortega A., Santeliz R., Valmore Bermúdez, Vera I.Fuentes:scopusMetabolic syndrome: Is it time to add the central nervous system?
ReviewAbstract: Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central obesity, hypPalabras claves:Alzheimer’s disease, Diabetes mellitus type 2, Insulin Resistance, Metabolic syndrome, Mild cognitive impair-mentAutores:Añez-Ramos R., Chávez-Castillo M., Dávila L.C.A., Díaz-Camargo E.A., Durán-Agüero S., González M.C., Gravini-Donado M., Nava M., Parra H., Pírela D., Rina Ortiz, Rojas M., Salazar-Vílchez J., Valmore BermúdezFuentes:scopus